By Fineline Cube 
The Thyroid Care Center on the JD Health platform, a joint initiative between German pharmaceutical major Merck KGaA (ETR: MRK) and JD Health International Inc., (HKG: 6618) the healthcare division of China’s e-commerce giant JD.com (NASDAQ: JD), officially launched this week. This innovative offering combines Merck’s expertise in thyroid and chronic disease management with JD’s technological strengths.
Integrated Thyroid Disease Management
The center leverages Merck’s innovative products and global resources in thyroid and chronic diseases, alongside JD’s capabilities in artificial intelligence, big data, the Internet of Things, and internet medicine. It provides the public and patients with comprehensive, personalized, and closed-loop management services for thyroid diseases, both online and offline.
Benefits for Patients
By offering scientifically and effectively managed treatment options, the Thyroid Care Center aims to enhance patients’ ability to manage thyroid conditions. This collaboration also contributes to improving overall awareness, diagnosis, and treatment rates of thyroid diseases.-Fineline Info & Tech